o. Univ.-Prof. Dr. Dr. Bernhard Keppler

Email: bernhard.keppler@univie.ac.at
Phone: +43-1-4277-52602

» CV
» Publications

Publications


Synthesis and in vivo anticancer evaluation of poly(organo) phosphazene-based metallodrug conjugates. / Hackl, Carmen M.; Schoenhacker-Alte, Beatrix; Klose, Matthias H. M. et al.
In: Dalton Transactions, Vol. 46, No. 36, 28.09.2017, p. 12114-12124.

Publications: Contribution to journalArticlePeer Reviewed


C,N-Cyclometalated ruthena(II)- and osma(II)cycles as anticancer agents. / Riedl, Christoph; Hejl, Michaela; Roller, Alexander et al.
2017. Paper presented at 17. Österreichische Chemietage 2017, Salzburg, Austria.

Publications: Contribution to conferencePaper


MERCURY TURNOVER IN DIFFERENT TYPES OF WATERBODIES. / Plessl, Christof; Christian, Christiane; Zechmeister, Thomas et al.
2017. Paper presented at 17. Österreichische Chemietage 2017, Salzburg, Austria.

Publications: Contribution to conferencePaper


Understanding the metabolism of the anticancer drug Triapine by electrochemical oxidation, in vitro and in vivo. / Pelivan, Karla; Frensemeier, Lisa ; Karst, Uwe et al.
2017. Paper presented at 17. Österreichische Chemietage 2017, Salzburg, Austria.

Publications: Contribution to conferencePaper


Multifunctional α vβ 6 Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting. / Conibear, Anne C.; Hager, Sonja; Mayr, Josef et al.
In: Bioconjugate Chemistry, Vol. 28, No. 9, 20.09.2017, p. 2429-2439.

Publications: Contribution to journalArticlePeer Reviewed


Platinum(IV) Complexes Featuring Axial Michael Acceptor Ligands - Synthesis, Characterization, and Cytotoxicity. / Sommerfeld, Nadine S.; Strohhofer, Daniel; Cseh, Klaudia et al.
In: European Journal of Inorganic Chemistry, Vol. 2017, No. 34, 15.09.2017, p. 4049-4054.

Publications: Contribution to journalArticlePeer Reviewed


USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] FOR THE TREATMENT OF CANCER. / Bakewell, Suzanne (Inventor); Sethuraman, Jyothi (Inventor); Keppler, Bernhard (Inventor).
Patent No.: WO2017151762 A1. Sept 08, 2017.

Publications: Patent


Understanding the metabolism of the anticancer drug Triapine: electrochemical oxidation, microsomal incubation and in vivo analysis using LC-HRMS. / Pelivan, Karla; Frensemeier, Lisa ; Karst, Uwe et al.
In: The Analyst, Vol. 142, No. 17, 07.09.2017, p. 3165-3176.

Publications: Contribution to journalArticlePeer Reviewed


Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes. / Hoefer, Doris; Varbanov, Hristo P.; Hejl, Michaela et al.
In: Journal of Inorganic Biochemistry, Vol. 174, 09.2017, p. 119-129.

Publications: Contribution to journalArticlePeer Reviewed


Distinctly enhanced anticancer activity in vivo by albumin-targeted platinum(IV) prodrugs. / Kowol, Christian; Heffeter, Petra; Mayr, Josef et al.
Book of Abstracts. 2017.

Publications: Contribution to bookContribution to proceedings


Impact of linker modification on the in vitro and in vivo anticancer activity of novel albumin-targeting Platinum (IV) drugs. / Schueffl, H.; Mayr, Josef; Groza, Diana et al.
Book of Abstracts. 2017.

Publications: Contribution to bookContribution to proceedings


On the molecular mechanism of action of organometallic anticancer drugs. / Gerner, Christopher; Meier, Samuel Matthias; Kreutz, Dominique et al.
Book of Abstracts. 2017.

Publications: Contribution to bookContribution to proceedings


Restoring cellular sensitivity to platinum-based drugs by targeted inhibition of STAT3. / Kiakos, Konstantinos; Jakupec, Michael; Valentine, Helen et al.
Book of Abstracts. 2017. p. 76.

Publications: Contribution to bookContribution to proceedings


Ruthenium-based drug interactions with lipid turnover in cancer cells revealed by correlative NanoSIMS and TEM imaging. / Legin, Anton; Schintlmeister, Arno; Eckhard, Margret et al.
Book of Abstracts: Metallomics 2017: The 6th International Symposium on Metallomics, 14. - 17.08.2017, University of Vienna, Vienna, Austria . Wien, 2017. p. 101.

Publications: Contribution to bookContribution to proceedings


Tackling adverse effects in cancer therapy: evaluation of poly(organo)phosphazene-based metallodrug conjugates. / Schönhacker-Alte, Beatrix; Hackl, Carmen; Klose, Matthias et al.
Book of Abstracts. 2017. p. 160.

Publications: Contribution to bookContribution to proceedings


Understanding the pharmacological behavior of the anticancer drug Triapine and its biologically active iron complex. / Pelivan, Karla; Miklos, Walter; Keppler, Bernhard et al.
Book of Abstracts. 2017. p. 76.

Publications: Contribution to bookContribution to proceedings


Oxaliplatin reacts with DMSO only in the presence of water. / Varbanov, Hristo P. (Corresponding author); Ortiz, Daniel; Hoefer, Doris et al.
In: Dalton Transactions, Vol. 46, No. 28, 28.07.2017, p. 8929-8932.

Publications: Contribution to journalArticlePeer Reviewed


Amidoxime platinum(II) complexes: pH-dependent highly selective generation and cytotoxic activity. / Bolotin, Dmitrii S. (Corresponding author); Demakova, Marina Ya.; Legin, Anton A. et al.
In: New Journal of Chemistry, Vol. 41, No. 14, 21.07.2017, p. 6840-6848.

Publications: Contribution to journalArticlePeer Reviewed


DNA or protein? Capillary zone electrophoresismass spectrometry rapidly elucidates metallodrug binding selectivity. / Artner, Christian; Holtkamp, Hannah U. ; Kandioller, Wolfgang et al.
In: Chemical Communications, Vol. 53, No. 57, 21.07.2017, p. 8002-8005.

Publications: Contribution to journalArticlePeer Reviewed


Post-digestion stabilization of osmium enables quantification by ICP-MS in cell culture and tissue. / Klose, Matthias H. M.; Hejl, Michaela; Heffeter, Petra et al.
In: The Analyst, Vol. 142, No. 13, 07.07.2017, p. 2327-2332.

Publications: Contribution to journalArticlePeer Reviewed